Recently, the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) trial was yet again criticized for its early termination. Furthermore, this is linked to gain from increased drug sales, decreased trial cost, and personal financial interests.1- 5 While we respect these opinions, we hold alternate views and suggest a solution.
Breimer LH, Mikhailidis DP. Trials by Independent Expert Bodies. Arch Intern Med. 2010;170(22):2042. doi:10.1001/archinternmed.2010.457